Inhibikase Therapeutics, Inc. (IKT) SEC Filings https://www.inhibikase.com/investors/sec-filings/all-sec-filings/rss Inhibikase Therapeutics, Inc. (IKT) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_36dbb71928886c79e446b0ffcae1c0b0/inhibikase/files/theme/images/logo-sm.png Inhibikase Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-352638/0001193125-26-352638.pdf Fri, 14 Aug 26 17:25:03 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-352638/0001193125-26-352638.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-097282/0001104659-26-097282.pdf Fri, 14 Aug 26 16:58:04 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-097282/0001104659-26-097282.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001875620-26-000017/0001875620-26-000017.pdf Thu, 13 Aug 26 11:49:57 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001875620-26-000017/0001875620-26-000017.pdf <![CDATA[S-8 - Securities to be offered to employees in employee benefit plans]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-344775/0001193125-26-344775.pdf Tue, 11 Aug 26 16:31:02 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-344775/0001193125-26-344775.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-344707/0001193125-26-344707.pdf Tue, 11 Aug 26 16:24:18 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-344707/0001193125-26-344707.pdf <![CDATA[8-K - Current report]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-344623/0001193125-26-344623.pdf Tue, 11 Aug 26 16:17:45 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-344623/0001193125-26-344623.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001346824-26-000206/0001346824-26-000206.pdf Fri, 31 Jul 26 16:34:00 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001346824-26-000206/0001346824-26-000206.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001231919-26-000815/0001231919-26-000815.pdf Fri, 31 Jul 26 16:32:56 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001231919-26-000815/0001231919-26-000815.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-328467/0001193125-26-328467.pdf Fri, 31 Jul 26 16:06:30 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-328467/0001193125-26-328467.pdf <![CDATA[8-K - Current report]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-323651/0001193125-26-323651.pdf Wed, 29 Jul 26 16:06:17 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-323651/0001193125-26-323651.pdf